Louis C. Lucido Bio Cor Rx Inc. (BICX) insider trading activity

Louis C. Lucido is President of BioCorRx Inc.. Currently has a direct ownership of 622,816 shares of BICX, which is worth approximately $236,670. The most recent transaction as insider was on Jun 28, 2024, when has been sold 44,220 shares (Common Stock, par value $0.001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 623K

0% 3M change

33.76% 12M change

Total Value Held $236,670

Louis C. Lucido Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	BUY Grant, award, or other acquisition	-	44,220 Added 6.63%	622,816 Common Stock, par valu...
May 31 2024	BUY Grant, award, or other acquisition	-	22,831 Added 3.8%	578,596 Common Stock, par valu...
Apr 30 2024	BUY Grant, award, or other acquisition	-	21,552 Added 3.73%	555,765 Common Stock, par valu...
Mar 28 2024	BUY Grant, award, or other acquisition	-	24,119 Added 4.32%	534,213 Common Stock, par valu...
Feb 29 2024	BUY Grant, award, or other acquisition	-	16,892 Added 3.21%	510,094 Common Stock, par valu...
Jan 31 2024	BUY Grant, award, or other acquisition	-	18,269 Added 3.57%	493,202 Common Stock, par valu...
Jan 16 2024	BUY Open market or private purchase	$88 $0.7 p/Share	126 Added 0.03%	474,933 Common Stock, par valu...
Jan 12 2024	BUY Open market or private purchase	$2,100 $0.7 p/Share	3,000 Added 0.63%	474,807 Common Stock, par valu...
Jan 02 2024	BUY Grant, award, or other acquisition	-	6,173 Added 1.29%	471,807 Common Stock, par valu...
Sep 29 2023	BUY Grant, award, or other acquisition	-	2,858 Added 0.61%	465,634 Common Stock, par valu...
Jun 30 2023	BUY Grant, award, or other acquisition	-	2,891 Added 0.62%	462,776 Common Stock, par valu...
Apr 03 2023	BUY Other acquisition or disposition	-	183,606 Added 28.53%	459,885 Common Stock, par valu...
Mar 31 2023	BUY Grant, award, or other acquisition	-	2,824 Added 2.62%	104,983 Common Stock, par valu...
Jan 30 2023	BUY Open market or private purchase	$552 $1.38 p/Share	400 Added 0.39%	102,159 Common Stock, par valu...
Jan 26 2023	BUY Open market or private purchase	$645 $1.29 p/Share	500 Added 0.49%	101,759 Common Stock, par valu...
Jan 24 2023	BUY Open market or private purchase	$240 $1.2 p/Share	200 Added 0.2%	101,259 Common Stock, par valu...
Jan 13 2023	BUY Open market or private purchase	$4,520 $1.13 p/Share	4,000 Added 3.81%	101,059 Common Stock, par valu...
Jan 03 2023	BUY Open market or private purchase	$2,200 $1.1 p/Share	2,000 Added 2.02%	97,059 Common Stock, par valu...
Dec 30 2022	BUY Grant, award, or other acquisition	-	5,319 Added 5.3%	95,059 Common Stock, par valu...
Dec 30 2022	BUY Open market or private purchase	$318 $1.01 p/Share	315 Added 0.35%	89,740 Common Stock, par valu...
Dec 12 2022	BUY Open market or private purchase	$4,200 $0.84 p/Share	5,000 Added 5.3%	89,425 Common Stock, par valu...
Oct 06 2022	BUY Open market or private purchase	$1,067 $1.84 p/Share	580 Added 0.68%	84,425 Common Stock, par valu...
Oct 05 2022	BUY Open market or private purchase	$2,020 $2.02 p/Share	1,000 Added 1.18%	83,845 Common Stock, par valu...
Sep 30 2022	BUY Grant, award, or other acquisition	-	2,450 Added 2.87%	82,835 Common Stock, par valu...
Sep 06 2022	BUY Open market or private purchase	$21 $2.1 p/Share	10 Added 0.01%	82,845 Common Stock, par valu...

LCL

Louis C. Lucido

President

Anaheim, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BICX shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cor Rx Inc. insider buys or sells BICX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCorRx Inc.

Track Activities on BICX

Account